University of Southampton Faculty of Medicine Tissue Bank
http://www.southampton.ac.uk/cruk/tcr/tissue.page
The Tissue Bank is licensed by the Human Tissue Authority (HTA) to source, organise, collect, prepare, store and distribute a diverse collection of human tissues and biological products. All tissue is collected with patient consent and distributed anonymously only to National Research Ethics Service (NRES) approved studies. This valuable resource is available to aid the study of cancer biology and other associated research. The Tissue Bank allows for rapid access to a plethora of biological materials supported by an inventory management system. Tissues currently available include normal and malignant snap frozen tissue, FFPE blocks, fresh biopsy tissues, blood products and biological fluids. Collections are organized by Tissue Bank staff and include a wide variety of cancer classifications. The Tissue Bank currently holds over 100,000 vials.
Existing samples:
- Malignant lymphoma (disorder)
- Malignant neoplasm of liver (disorder)
- Malignant neoplasm of skin (disorder)
- Malignant tumor of breast (disorder)
- Malignant tumor of colon (disorder)
- Malignant tumor of kidney (disorder)
- Malignant tumor of lung (disorder)
- Malignant tumor of ovary (disorder)
- Malignant tumor of prostate (disorder)
- Malignant tumor of thyroid gland (disorder)
- Osteosarcoma of bone (disorder)
Networks
- Confederation of Cancer Biobanks The NCRI’s Confederation of Cancer Biobanks (CCB) is a consortium of biobanks and biosample collections based in the UK, established to encourage greater coordination and promote harmonisation between biobanks – enabling them to share best practice and raise awareness of their collections with researcher
Contact Information
- Email:
- kp1@soton.ac.uk
- Address:
-
Somers Cancer Research Building
University ot Southampton
Mailpoint 824
Tremona Road
Southampton
Hampshire
SO16 6YD
England
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2018 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |